Dr. Brian C. Boulmay
Claim this profileUniversity Medical Center New Orleans
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
18 reported clinical trials
30 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage II
Stage I
2Non-Small Cell Lung Cancer
Stage IV
Stage II
Stage III
Affiliated Hospitals
University Medical Center New Orleans
Louisiana State University Health Science Center
Clinical Trials Brian C. Boulmay is currently running
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
More about Brian C. Boulmay
Clinical Trial Related4 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Brian C. Boulmay has experience with
- Pembrolizumab
- Cisplatin
- Carboplatin
- Pemetrexed
- Intensity-Modulated Radiation Therapy
- Biospecimen Collection
Breakdown of trials Brian C. Boulmay has run
Lung Cancer
Non-Small Cell Lung Cancer
Skin Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Brian C. Boulmay specialize in?
Brian C. Boulmay focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage II.
Is Brian C. Boulmay currently recruiting for clinical trials?
Yes, Brian C. Boulmay is currently recruiting for 10 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Brian C. Boulmay has studied deeply?
Yes, Brian C. Boulmay has studied treatments such as Pembrolizumab, Cisplatin, Carboplatin.
What is the best way to schedule an appointment with Brian C. Boulmay?
Apply for one of the trials that Brian C. Boulmay is conducting.
What is the office address of Brian C. Boulmay?
The office of Brian C. Boulmay is located at: University Medical Center New Orleans, New Orleans, Louisiana 70112 United States. This is the address for their practice at the University Medical Center New Orleans.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.